Ophthalmic Technician

GT Independence strengthens leadership team: appoints Chris Karkenny as CEO. Aug 31, 2026, 09:00 ET STURGIS, Mich., Aug. 31, 2026 /PRNewswire/ - GT Independence, a leading financial management services (FMS) company focused on helping people self-direct their long-term care and support services at home and in community-based settings, has named Chris Karkenny as chief executive officer. Karkenny brings proven experience in accelerating growth while maintaining operational excellence. The appointment comes as GT Independence expands its national reach. Today the company serves more than 60,000 people self-directing their care in more than 21 states. He joins a leadership team with deep expertise in self-direction, including President D. Pearl Barnett and John Carmichael, GT Independence's founder and former CEO, who will continue to support the company as a member of the board. "My family established GT Independence to give people who need long-term services and supports greater control over who provides their care and more independence in how they live their lives," said Carmichael, whose family retains an ownership interest in the FMS. "Chris has a deep appreciation for our mission and a clear vision for how GT Independence can further extend its impact across the country. I look forward to this next chapter of our company's development." Karkenny joins GT Independence from NVISION Eye Centers, where he served as CEO since 2018 and led the organization to become one of the nation's fastest-growing ophthalmology companies. His leadership experience in managing high-growth environments spans more than 25 years. Karkenny's experience has been focused primarily within the healthcare sector and includes leading organizations through periods of significant growth. "GT Independence is a national leader in self-direction because of the commitment and expertise of its people," said Karkenny. "The team has built a strong culture centered on serving thousands of participants, families and caregivers while helping state Medicaid agencies and managed care organizations operate high-quality, compliant programs. I am honored to join this talented group and excited to work alongside them to build on GT Independence's strong foundation, expand its reach and help more people live their lives with greater choice and independence." "We're excited to welcome Chris to the GT Independence team," added Barnett. "Throughout his career, he has consistently put people first, ensuring their voices and experiences shape the way services are delivered. His commitment to person-centered support aligns perfectly with GT Independence's mission and values. As we continue to innovate, strengthen our customer experience and expand access to self-direction, Chris' leadership will ensure we remain focused on the people we serve." About GT Independence GT Independence is a national financial management service provider that supports individuals participating in self-direction programs. The organization is dedicated to promoting personal choice, independence, and quality of life by delivering reliable, person-centered financial and administrative services. With a growing national footprint, GT Independence continues to expand its impact through innovation, service excellence, and a strong commitment to its people. More information is at gtindependence.com. SOURCE GT Independence

ALISO VIEJO, Calif.--(BUSINESS WIRE)--NVISION Eye Centers, a renowned national leader in comprehensive eye care services, proudly announces the remarkable expansion of its subsidiary, NVISION Clinical Research, LLC. Spearheaded by the visionary leadership of its President and GM, Michael Gibertini, PhD, who assumed the role in August 2023, NVISION Clinical Research has swiftly expanded both its range of trials as well as the number of key investigators to lead this innovation. NVISION Clinical Research, LLC, an integral member of the NVISION family, is exclusively dedicated to facilitating clinical trial opportunities to patients treated by NVISION ophthalmologists. With more than 40 physician investigators across 20 clinical trial sites, NVISION Clinical Research, LLC operates one of the largest ophthalmology-specialized clinical trial site networks nationwide. The company remains committed to adding new investigators from NVISION’S expanding platform of more than 100 practice partners throughout the USA. “We are delighted to welcome Dr